Management of antibiotic-resistant infection in the newborn

Archives of Disease in Childhood: Education and Practice Edition

Volumn 96, Issue 4, 2011, Pages 122-127

  Gray, James William ^a   Patel, Mitul ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; CEFOTAXIME; CEFTAROLINE; CEFTAZIDIME; CEFTOBIPROLE; CEFTRIAXONE; CLINDAMYCIN; COLISTIN; DALBAVANCIN; DAPTOMYCIN; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; IMIPENEM; IMMUNOGLOBULIN; LINEZOLID; MEROPENEM; ORITAVANCIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; TELAVANCIN; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ADD ON THERAPY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CONTINUOUS INFUSION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG TREATMENT FAILURE; ENTEROBACTERIACEAE INFECTION; ENTEROCOCCAL INFECTION; ESCHERICHIA COLI; GASTROINTESTINAL SYMPTOM; GLYCOPEPTIDE RESISTANT ENTEROCOCCUS INFECTION; HUMAN; KIDNEY DYSFUNCTION; MENINGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONOTHERAPY; MYOSITIS; NEWBORN INFECTION; NONHUMAN; PATIENT CARE; PNEUMOCOCCAL INFECTION; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS PNEUMONIA; REVIEW; RHABDOMYOLYSIS; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOPENIA;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CARBAPENEMS; COLISTIN; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT, NEWBORN; OXAZOLIDINONES; VANCOMYCIN;

EID: 79960460809     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2010.199653     Document Type: Review

References (37)

1. Johnson AP, Sharland M, Goodall CM, et al. Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland. Arch Dis Child 2010;95:781-5.
2. Gould IM, Girvan EK, Browning RA, et al. Report of a hospital neonatal unit outbreak of community-associated methicillin-resistant Staphylococcus aureus. Epidemiol Infect 2009;137:1242-8.
3. van Hal SJ, Paterson DL. Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates. Antimicrob Agents Chemother 2011;55:405-10.
4. McAdams RM, Garza-Cox S, Yoder BA. Early-onset neonatal pneumococcal sepsis syndrome. Pediatr Crit Care Med 2005;6:595-7. (Pubitemid 41306765)
5. Ergaz Z, Arad I, Bar-Oz B, et al. Elimination of vancomycin-resistant enterococci from a neonatal intensive care unit following an outbreak. J Hosp Infect 2010;74:370-6.
6. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009;66:82-98.
7. Hope R, Livermore DM, Brick G, et al.; BSAC Working Parties on Resistance Surveillance. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008;62(Suppl 2):ii65-74.
8. PVL Sub-Group of the Steering Group on Healthcare Associated Infection. Guidance on the Diagnosis and Management of PVL-Associated Staphylococcus aureus Infections (PVL-SA) in England. 2nd edition. London: Health Protection Agency, 2008.
9. Shama A, Patole SK, Whitehall JS. Intravenous rifampicin in neonates with persistent staphylococcal bacteraemia. Acta Paediatr 2002;91:670-3. (Pubitemid 34779329)
10. Beibei L, Yun C, Mengli C, et al. Linezolid versus vancomycin for the treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials. Int J Antimicrob Agents 2010;35:3-12.
11. Kalil AC, Murthy MH, Hermsen ED, et al. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis. Crit Care Med 2010;38:1802-8.
12. Deville JG, Adler S, Azimi PH, et al. Linezolid versus vancomycin in the treatment of known or suspected resistant Gram-positive infections in neonates. Pediatr Infect Dis J 2003;22:S158-63.
13. Pankey GA, Sabath LD. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis 2004;38:864-70. (Pubitemid 38387236)
14. Cohen-Wolkowiez M, Smith PB, Benjamin DK Jr, et al. Daptomycin use in infants: report of two cases with peak and trough drug concentrations. J Perinatol 2008;28:233-4.
15. Sarafidis K, Iosifidis E, Gikas E, et al. Daptomycin use in a neonate: serum level monitoring and outcome. Am J Perinatol 2010;27:421-4.
16. Cantón R, Ruiz-Garbajosa P, Chaves RL, et al. A potential role for daptomycin in enterococcal infections: what is the evidence? J Antimicrob Chemother 2010;65:1126-36.
17. Steed ME, Rybak MJ. Ceftaroline: a new cephalosporin with activity against resistant Gram-positive pathogens. Pharmacotherapy 2010;30:375-89.
18. Schirmer PL, Deresinski SC. Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections. Expert Rev Anti Infect Ther 2009;7:777-91.
19. Guskey MT, Tsuji BT. A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin. Pharmacotherapy 2010;30:80-94.
20. Abdel-Hady H, Hawas S, El-Daker M, et al. Extended-spectrum beta-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit. J Perinatol 2008;28:685-90.
21. Lytsy B, Sandegren L, Tano E, et al. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 2008;116:302-8. (Pubitemid 351499162)
22. Tiskumara R, Fakharee SH, Liu CQ, et al.; Asia-Pacific Neonatal Infections Study. Neonatal infections in Asia. Arch Dis Child Fetal Neonatal Ed 2009;94:F144-8.
23. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010;65:1119-25.
24. Lumbiganon P, Kosalaraska P, Teeratakulpisarn J, et al. Carbapenem-resistant Acinetobacter baumannii septicemia and meningitis in a neonate treated with colistin and netilmycin. J Pediatr Infect Dis 2008;3:283-5.
25. Markantonis SL, Markou N, Fousteri M, et al. Penetration of colistin into cerebrospinal fluid. Antimicrob Agents Chemother 2009;53:4907-10.
26. Dalgic N, Ceylan Y, Sancar M, et al. Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin. Ann Trop Paediatr 2009;29:141-7.
27. Ray L, Levasseur K, Nicolau DP, et al. Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritis. Ann Pharmacother 2010;44:582-6.
28. Doan TL, Fung HB, Mehta D, et al. Tigecycline: a glycylcycline antimicrobial agent. Clin Ther 2006;28:1079-106. (Pubitemid 44376809)
29. Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006;43(Suppl 2):S43-8.
30. Touati A, Achour W, Cherif A, et al. Outbreak of Acinetobacter baumannii in a neonatal intensive care unit: antimicrobial susceptibility and genotyping analysis. Ann Epidemiol 2009;19:372-8.
31. McGrath EJ, Chopra T, Abdel-Haq N, et al. An outbreak of carbapenem-resistant Acinetobacter baumannii infection in a neonatal intensive care unit: investigation and control. Infect Control Hosp Epidemiol 2011;32:34-41.
32. Nakwan N, Wannaro J, Thongmak T, et al. Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Pediatr Pulmonol 2011;46:60-6.
33. Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs 2009;69:1879-901.
34. Moissenet D, Salauze B, Clermont O, et al. Meningitis caused by Escherichia coli producing TEM-52 extended-spectrum beta-lactamase within an extensive outbreak in a neonatal ward: epidemiological investigation and characterization of the strain. J Clin Microbiol 2010;48:2459-63.
35. Cassettari VC, da Silveira IR, Dropa M, et al. Risk factors for colonisation of newborn infants during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an intermediate-risk neonatal unit. J Hosp Infect 2009;71:340-7.
36. Wiener-Well Y, Rudensky B, Yinnon AM, et al. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. J Hosp Infect 2010;74:344-9.
37. Patel SJ, Oshodi A, Prasad P, et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance. Pediatr Infect Dis J 2009;28:1047-51.